scholarly journals 087 Oxidative stress implication in cardiogenic shock with ischemic or idiopathic severe left ventricular dysfunction: role of etiologies of cardiomyopathies

2010 ◽  
Vol 2 (1) ◽  
pp. 29 ◽  
Author(s):  
Jean-Christophe Charniot ◽  
Claudine Cosson ◽  
Franck Chemouni ◽  
Noelle Vignat ◽  
Vera Bogdanova ◽  
...  
2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
B Picarra ◽  
J A Pais ◽  
A R Santos ◽  
M Carrington ◽  
D Bras ◽  
...  

Abstract Background The presence of cardiogenic shock (CS) after ST-elevation acute myocardial infarction (STEMI) is associated with a high mortality. Traditionally, severe left ventricular dysfunction is assumed to be the main predictor of CS, however trials and registries show that in average left ventricular function is only moderately depressed in CS after acute myocardial infarction. Purpose To characterize the population of patients (Pts) with CS after STEMI but without severe left ventricular dysfunction and assess their impact in mortality. Methods From a national multicenter registry, we evaluated 7181 Pts with STEMI and ejection fraction (EF) >30%, and excluded all pts with STEMI and an EF<30%. We considered 2 groups: Group 1 – Pts who developed CS and Group 2 - Pts who didn't developed CS. We registered age, gender, cardiovascular and non-cardiovascular co-morbidities, electrocardiographic presentation, vital signs at admission, reperfusion strategies, reperfusion times and coronary anatomy. We evaluated the following in-hospital complications: Re-Infarction, mechanical complications, high-grade atrial ventricular block, sustained ventricular tachycardia (VT) atrial fibrillation (AF) and stroke. We compared the in-hospital mortality. Results The presence of CS without severe left ventricular dysfunction was observed in 5,2% pts (n=376), being CS present at admission in 51,2% of these pts. The mean EF was lower in group 1 pts (44% ± 11 vs 51±11%, p<0,001). Patients in group 1 were older (70±14 vs 63±13 years, p<0,001), more females (39,4% vs 23,3%, p<0,001), had a higher prevalence of previous valvular heart disease (2,7% vs 1,0%, p=0,005), heart failure (4,8% vs 1,4%, p<0,001, peripheral artery disease (5,5% vs 2,9%, p=0,004), chronic kidney disease (6,4% vs 2,7%, p<0,001) and chronic pulmonary obstructive disease (8,2% vs 3,1%, p<0,001). At admission, Group 1 pts had more atrial fibrillation (10,4% vs 4,4%, p<0,001) and received less reperfusion (77,7% vs 83,0%, p=0,008), without differences in the type of reperfusion or times to reperfusion. The presence of multivessel disease (60,0% vs 45,7%, p<0,001) and left main disease (6,6% vs 2,4%, p<0,001) were more prevalent in Group 1 pts. Group 1 pts had more in-hospital complications: Re-Infarction (3,5% vs 0,7%, p<0,001), AF (22,1% vs 5,0%, p<0,001), mechanical complications (9,6% vs 0,5%, p<0,001), high atrial ventricular block (26,7% vs 3,7%, p<0,001), VT (10,6% vs 1,9%, p<0,001), stroke (1,9% vs 0,6%, p=0,01) and major bleeding (10,4% vs 1,5%, p<0,001). In-hospital mortality was much higher in Group 1 pts (26,6% vs 1,4%, p<0,001). Conclusions Cardiogenic shock is present in 5,2% of STEMI pts without severe ventricular dysfunction. These pts were older, more frequent female, had higher morbidities and in-hospital complications. Even without severe ventricular dysfunction, cardiogenic shock in these patients was associated with much higher in-hospital mortality.


2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
B.C Picarra ◽  
A.R Santos ◽  
J.A Pais ◽  
M Carrington ◽  
D Bras ◽  
...  

Abstract Introduction Traditionally, severe left ventricular dysfunction is assumed to be the main predictor of CS afte acute myocardial infarction (AMI), however trials and registries show that in average left ventricular function is only moderately depressed in CS after acute myocardial infarction. Purpose To characterize the population of patients (Pts) with CS after AMI but without severe left ventricular dysfunction (defined as ejection fraction &gt;30%) and assess their impact in mortality. Methods From a national multicenter registry, we evaluated 16332 Pts with AMI and ejection fraction (EF) &gt;30%. We considered 2 groups: Group 1 – Pts who developed CS and Group 2 – Pts who didn't developed CS. We registered age, gender, cardiovascular and non-cardiovascular co-morbidities, electrocardiographic presentation and coronary anatomy. We also evaluated the following in-hospital complications: Re-Infarction, mechanical complications, high-grade atrial ventricular block, sustained ventricular tachycardia (VT) atrial fibrillation (AF) and stroke. We compared the in-hospital mortality. Results The presence of CS without severe left ventricular dysfunction was observed in 3,2% pts (n=518) with AMI, being CS present at admission in 46,8% of these pts. The mean EF was lower in group 1 pts (44% ± 11 vs 53±11%, p&lt;0,001). Patients in group 1 were older (71±13 vs 65±13 years, p&lt;0,001), more females (38,8% vs 26,6%, p&lt;0,001), had a higher prevalence of previous valvular heart disease (6,1% vs 3,0%, p&lt;0,001), heart failure (10,1% vs 4,8%, p&lt;0,001, peripheral artery disease (7,5% vs 5,3%, p=0,03), chronic kidney disease (9,8% vs 5,4%, p&lt;0,001), chronic pulmonary obstructive disease (9,1% vs 4,9%, p&lt;0,001) and previous stroke (11,0% vs 7,2%, p&lt;0,001). At admission, Group 1 pts had more ST-elevation AMI (72,6% vs 43,0%, p&lt;0,001), more AF (11,4% vs 6,6%, p&lt;0,001) and more right bundle block (9,9%% vs 5,8%, p&lt;0,001). Group 1 patients received less coronary angiography (80,9% vs 88,2%, p&lt;0,00. The presence of multivessel disease (64,3% vs 51,4%, p&lt;0,001), left main disease (12,2% vs 7,2%, p&lt;0,001), left anterior descending disease (72,4% vs 64,3%, p&lt;0,001) and right coronary disease (64,8% vs 55,5%, p&lt;0,001) were more prevalent in Group 1 pts. Group 1 pts had more in-hospital complications: Re-Infarction (4,4% vs 0,9%, p&lt;0,001), AF (23,0% vs 4,3%, p&lt;0,001), mechanical complications (8,9% vs 0,3%, p&lt;0,001), high atrial ventricular block (21,9% vs 2,3%, p&lt;0,001), VT (10,8% vs 1,2%, p&lt;0,001) and major bleeding (8,9% vs 1,3%, p&lt;0,001). In-hospital mortality was also much higher in Group 1 pts (29,5% vs 1,2%, p&lt;0,001). Conclusions Cardiogenic shock is present in 3,2% of AMI pts without severe ventricular dysfunction. These pts were older, more frequent female, had higher morbidities and in-hospital complications. Even without severe ventricular dysfunction, cardiogenic shock in these patients was associated with a much higher in-hospital mortality. Funding Acknowledgement Type of funding source: None


Sign in / Sign up

Export Citation Format

Share Document